Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neural Transm Suppl ; (71): 229-36, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17447433

RESUMEN

We have quantitated CSF and serum levels of Selenium, iron, copper and zinc by Atomic absorption spectrophotometer in 36 patients with parkinson's disease all on L-dopa therapy. Out of these 19 showed on or positive response to L-dopa where as 21 patients showed on and off response. These data were compared with 21 healthy controls. The results showed that serum levels of iron, copper and zinc remained unchanged where as in CSF, significant decrease in zinc was found in both on and on/off PD patients indicating the deficiency of zinc which continues in the worsening clinical condition of off patients. The level of copper remained unchanged in both on and on/off PD patients. Iron and selenium increase in CSF of both patients which is a clear evidence of relationship between increased iron and selenium level in brain which could be correlated with decrease in dopamine levels and oxidative stress in PD Patients.


Asunto(s)
Metales Pesados/sangre , Metales Pesados/líquido cefalorraquídeo , Enfermedad de Parkinson/sangre , Enfermedad de Parkinson/líquido cefalorraquídeo , Selenio/sangre , Selenio/líquido cefalorraquídeo , Anciano , Análisis de Varianza , Antiparkinsonianos/uso terapéutico , Estudios de Casos y Controles , Cobre , Femenino , Humanos , Hierro , Levodopa/uso terapéutico , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/tratamiento farmacológico , Espectrofotometría Atómica/métodos , Zinc
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA